Literature DB >> 10992302

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.

R J Jaju1, M Jones, J Boultwood, S Kelly, D Y Mason, J S Wainscoat, L Kearney.   

Abstract

The 5q- syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory anemia, deletion of the long arm of chromosome 5, del(5q), as the sole cytogenetic abnormality, and a low frequency of transformation to acute leukemia. Using combined immunophenotyping and fluorescence in situ hybridization (FISH), studies were carried out on bone marrow smears of three 5q- syndrome cases to identify the cell lineages carrying the 5q deletion. In all three cases, the granulocytic, monocytic, and erythroid lineages possessed the del(5q) clonal marker, whereas the T-lymphocytes did not. Interestingly, in one case, cells of B-lymphoid lineage also showed the presence of the del(5q). This is the first report to date showing involvement of an acquired 5q deletion associated with MDS in B-cells. This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992302     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1035>3.0.co;2-l

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion.

Authors:  Martin Jädersten
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

2.  Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient.

Authors:  Dandan Liu; Suning Chen; Jinlan Pan; Mingqing Zhu; Ni Wu; Feng Zhu; Zixing Chen
Journal:  Int J Hematol       Date:  2012-10-09       Impact factor: 2.490

3.  Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.

Authors:  Ting Xi Liu; Yi Zhou; John P Kanki; Min Deng; Jennifer Rhodes; Hong Wei Yang; Xiao Ming Sheng; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.

Authors:  Chun-Mei Fu; Zi-Xing Chen; Dan-Dan Liu; Jun Zhang; Jin-Lan Pan; Jian-Ying Liang
Journal:  Int J Hematol       Date:  2014-11-28       Impact factor: 2.490

Review 5.  Clonality in the myelodysplastic syndromes.

Authors:  Jacqueline Boultwood; James S Wainscoat
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

6.  Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.

Authors:  Andrea Pellagatti; Martin Jädersten; Ann-Mari Forsblom; Helen Cattan; Birger Christensson; Emma K Emanuelsson; Mats Merup; Lars Nilsson; Jan Samuelsson; Birgitta Sander; James S Wainscoat; Jacqueline Boultwood; Eva Hellström-Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-18       Impact factor: 11.205

7.  Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

Authors:  Yoshihiro Oka; Akihiro Tsuboi; Masaki Murakami; Manabu Hirai; Nobuhiko Tominaga; Hiroko Nakajima; Olga A Elisseeva; Tomoki Masuda; Akiko Nakano; Manabu Kawakami; Yusuke Oji; Kazuhiro Ikegame; Naoki Hosen; Keiko Udaka; Masaki Yasukawa; Hiroyasu Ogawa; Ichiro Kawase; Haruo Sugiyama
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 8.  Recent Advances in the 5q- Syndrome.

Authors:  Andrea Pellagatti; Jacqueline Boultwood
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-20       Impact factor: 2.576

9.  Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis.

Authors:  Timothy A Graubert; Michelle A Payton; Jin Shao; Richard A Walgren; Ryan S Monahan; John L Frater; Mark A Walshauser; Mike G Martin; Yumi Kasai; Matthew J Walter
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

10.  Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.

Authors:  Andrea Pellagatti; Eva Hellström-Lindberg; Aristoteles Giagounidis; Janet Perry; Luca Malcovati; Matteo G Della Porta; Martin Jädersten; Sally Killick; Carrie Fidler; Mario Cazzola; James S Wainscoat; Jacqueline Boultwood
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.